ISHARES TR - ISHARES BIOTECH - Put

Historical Holders from Q1 2014 to Q3 2025

Type / Class: Equity / ISHARES BIOTECH
Price per share: $144.37
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 8,000
Total reported value: $1,154,000
% of total 13F portfolios: 0%
Share change: +5,200
Value change: +$750,100
Avg buy value change: +0%
Number of holders: 1

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, ISHARES TR - ISHARES BIOTECH - Put has 1 institutional shareholder filing 13F forms. They hold 8,000 shares. .

Institutional Holders of ISHARES TR - ISHARES BIOTECH - Put across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q3	8,000	$1,154,000	+$750,100	$41,078,987		14,437%	1
2025 Q2	2,800	$354,000	+$354,000	$14,245,026		12,651%	1
2025 Q1	0	$0	-$1,361,000	$10,654,070		12,790%	0
2024 Q4	10,300	$1,361,000	+$1,361,000	$21,523,788		13,221%	1
2024 Q3				$36,065,120		14,560%	3
2024 Q2				$38,079,792		13,726%	4
2024 Q1	0	$0	-$203,000	$54,402,014		13,650.1%	4
2023 Q4	1,500	$203,000	+$203,000	$57,818,238		13,585%	5
2023 Q3				$65,923,047		12,229%	4
2023 Q2	0	$0	-$348,000	$125,997,093		12,696%	5
2023 Q1	2,700	$348,000	+$348,000	$64,269,383		12,916%	6
2022 Q4				$55,482,141		13,129%	4
2022 Q3				$54,742,000		11,694.87%	3
2022 Q2				$957,959,000		11,415.23%	3
2022 Q1	0	$0	-$900,000	$44,515,000		12,743.49%	4
2021 Q4	5,900	$900,000	-$1,571,187	$34,927,000		13,314.29%	5
2021 Q3	16,200	$2,619,000	+$2,619,001	$842,000		16,160%	3
2021 Q2	0	$0	-$617,000	$58,407,000		16,363.64%	3
2021 Q1	4,100	$617,000	+$617,000	$13,942,000		15,055.71%	3
2020 Q4				$14,745,000		15,148.28%	5
2020 Q3				$35,259,000		13,620.75%	5
2020 Q2	0	$0	-$646,000	$20,790,000		690,262.7%	2
2020 Q1	6,000	$646,000	+$646,000	$15,526,000		10,774.84%	4
2019 Q4				$17,992,000		12,050.06%	4
2019 Q3				$14,801,000		5,727.42%	0
2019 Q2				$64,504,000		10,819.58%	4
2019 Q1				$82,447,000		11,179.45%	0
2018 Q4	0	$0	-$2,536,000	$42,967,000		9,625%	0
2018 Q3	20,800	$2,536,000	+$2,536,000	$38,246,000		6,259.3%	4
2018 Q2				$49,024,000		10,982.04%	4
2018 Q1				$44,002,000		10,666.67%	5
2017 Q4				$30,100,000		10,666.67%	5
2017 Q3				$12,150,000	$0	33,055.92%	3
2017 Q2				$9,798,000	$62,000	31,000%	5
2017 Q1				$186,780,000		29,327.21%	5
2016 Q4				$80,684,000		26,538%	3
2016 Q3				$166,978,000		28,945.64%	4
2016 Q2				$220,734,000	$0	25,733.96%	8
2016 Q1				$165,086,000	$112,852,000	26,080%	7
2015 Q4				$225,346,000		33,832.83%	5
2015 Q3	15,000	$4,543,000	+$4,543,001	$368,509,000		30,332.75%	6
2015 Q2	0	$0	-$176,000	$333,273,000		36,897%	7
2015 Q1	16,100	$176,000	+$15,000	$172,527,000		34,371.61%	6
2014 Q4				$117,887,000		30,335.1%	3
2014 Q3				$106,391,000		27,360%	3
2014 Q2				$86,251,000		25,374.27%	2
2014 Q1				$77,379,000		23,632.44%	4